Home Health Care News June 21, 2022
Andrew Donlan

In November, MedArrive had a significant jumping-off point established. It was worth $25 million, raised through a Series A and led by the venture capital fund Section 32.

Its goal was to make “tens of thousands” of at-home visits in the next year, CEO Dan Trigub told Home Health Care News at the time.

It has found multiple ways to do just that. But like many other home-based care companies, it’s also used COVID-19 as a jumping off point. For instance, a recent partnership with the health plan Health Net has allowed it to vaccinate more individuals from the virus in their homes.

That allows MedArrive to vaccinate vulnerable individuals, for one, but it also sets them up to eventually...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Health System / Hospital, Home, Patient / Consumer, Provider
FDA spends $1.2M on VR-enabled hub to spur development of at-home care devices
FDA launches initiative to advance home healthcare models, devices
Novant Health launches 'hospital at home' with $2.7M donation
FDA initiative puts AR/VR at heart of home health drive
Understanding the Value of the Home as a Healthcare Site

Share This Article